Isosteviol and Antidepressant Combination Disrupts Gut Bacteria, Study Finds
A laboratory study has revealed that isosteviol, a sweetener derived from the stevia plant, can significantly disrupt the growth of beneficial gut bacteria when combined with the antidepressant duloxetine, according to research published in *Molecular Systems Biology*. The findings highlight potential interactions between commonly consumed sweeteners and medications, though the study was conducted in a controlled lab environment and does not confirm effects in humans.
The study, led by researchers at the University of Cambridge’s MRC Toxicology Unit, tested 39 commercially available sweeteners against 25 gut bacterial strains. It found that three-quarters of the sweeteners directly affected the growth of at least one bacterial strain. The most striking result involved isosteviol, which suppressed two key gut bacteria—*Roseburia intestinalis* and *Parabacteroides merdae*—when combined with duloxetine. These bacteria are associated with blood sugar regulation, intestinal health, and immune function. The combined effect was stronger than either compound alone, according to the researchers.
Lab Study Reveals Complex Interactions Between Sweeteners and Gut Microbes
The research team evaluated sweeteners ranging from natural options like stevia and monk fruit to synthetic ones such as saccharin and aspartame. Each sweetener was tested individually against gut bacteria, producing 975 unique pairings. The study also explored interactions between sweeteners and four commonly consumed compounds: caffeine, vanillin (a flavoring agent), advantame (another sweetener), and duloxetine. This expanded analysis identified over 100 previously unreported interactions, with 34 combinations amplifying the impact on gut bacteria.
The strongest interaction occurred between isosteviol and duloxetine, which reduced *Roseburia intestinalis* growth by up to 80% in some experiments. *Parabacteroides merdae*, another critical gut bacterium, also saw significant suppression. Researchers emphasized that the experiments were conducted in vitro, meaning the results do not directly translate to human physiology. However, the scale of the study—testing 39 sweeteners across 25 bacterial species—provides new insights into how these compounds might influence the gut microbiome.
Antidepressants and Sweeteners: A Growing Area of Concern
Duloxetine, the antidepressant involved in the study, is one of the most prescribed medications in the U.S., with over 4.2 million prescriptions filled in 2023, according to drug databases. Its widespread use raises questions about potential interactions with sweeteners, which are also ubiquitous in modern diets. The study’s lead author, Dr. Sonja Blasche, noted that sweeteners are rarely consumed in isolation, often mixing with other substances in food, beverages, or medications.
The combined effects of sweeteners and other compounds may be more complex than previously thought,
Blasche said. The research suggests that interactions between sweeteners and medications could alter gut bacterial communities, potentially impacting metabolic and immune functions. However, the study does not establish a causal link between these changes and specific health outcomes.
Experts Warn of Limitations and Call for Further Research
While the findings underscore the need to better understand how sweeteners interact with the gut microbiome, experts caution against overinterpreting the results. Professor Kiran Patil, a co-author of the study, noted that sweeteners are often marketed as metabolically inactive,
but the research challenges this assumption. Our study shows they can directly influence gut bacteria, which may have broader implications for health,
he said.
However, the study’s lab-based nature means its relevance to human health remains uncertain. Dr. Patil emphasized that more research is needed to determine whether these bacterial changes translate to meaningful health effects.
The findings also highlight the importance of considering how dietary and pharmaceutical compounds interact, particularly as both sweeteners and antidepressants are widely used.
Practical Implications for Consumers
For now, the study does not provide actionable advice for consumers, but it adds to growing concerns about the long-term effects of sweeteners on gut health. Researchers stress that the gut microbiome plays a critical role in metabolism, immunity, and even mental health, though the link between sweetener use and cognitive decline is not addressed in the study.
The study’s authors recommend further investigation into how sweeteners and medications interact in real-world conditions. Until more is known, they advise caution in combining sweeteners with other substances, particularly medications. As Dr. Blasche noted, Understanding these interactions could help inform safer dietary and pharmaceutical practices.
The research underscores the complexity of modern diets and the need for ongoing scrutiny of seemingly harmless additives. While isosteviol and duloxetine’s combined effect on gut bacteria is concerning, the study’s authors stress that no definitive conclusions can be drawn about human health risks at this time.
Worth a look
